Cinctive Capital Management LP Edwards Lifesciences Corp Transaction History

Cinctive Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $2.42 Million - $3.19 Million	33,333 New	33,333 $3.19 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $2.84 Million - $3.64 Million	41,599 New	41,599 $3.1 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.04 Million - $1.55 Million	-12,064 Reduced 32.06%	25,560 $2.43 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $3.5 Million - $4.4 Million	-34,309 Reduced 47.7%	37,624 $4.43 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $6.61 Million - $8.12 Million	62,110 Added 632.29%	71,933 $9.32 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $5.87 Million - $7 Million	-57,006 Reduced 85.3%	9,823 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $5.38 Million - $6.73 Million	64,212 Added 2453.65%	66,829 $6.92 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $205,905 - $237,283	2,617 New	2,617 $219,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.